Skip to content

A study to test the effectiveness of Gojivha Danti lepa in treating Napkin Rash.

Randomized controlled clinical trial to evaluate the efficacy of Gojivha Danti Lepa in the management of Ahiputana w.s.r. to Napkin Rash. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090339
Enrollment
60
Registered
2025-07-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L22- Diaper dermatitis

Interventions

None listed

Sponsors

Dr Uttara Sanjay Gandhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children with signs and symptoms of Ahiputana like kandu,daha,strav,pitika.

Exclusion criteria

Exclusion criteria: Children with any systemic disorder like Acute gastro-enteritis , enteritis with dehydration, Bacillary Dysentry, Helminthic infection,lactogenic intolerance,secondary infection,etc,any other skin diseases like atopic dermatitis and generalised skin infection.

Design outcomes

Primary

MeasureTime frame
The primary outcome focuses on the clinical efficacy of Gojivha Danti lepa in managing Ahiputana .It will be assessed based on symptomatic relief (Kandu, Area covered by rash, Strava and Color) and objective parameter (Pidika).Timepoint: 7 days treatment with 3 follow-ups on 3rd, 5th and 7th day.

Secondary

MeasureTime frame
Gojivha Danti lepa is more effective than ezinapi ointment in the management of AhiputanaTimepoint: 7 days treatment with 3 follow-ups on 3rd, 5th & 7th day

Countries

India

Contacts

Public ContactDr Udaykumar Koli

Late Kedari Redekar Ayurvedic Mahavidyalaya

udaykoli007@gmail.com9420930090

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026